The Role of TIM-1: TIM-4 Pathway in Allograft Rejection and Tolerance
TIM-1:TIM-4 通路在同种异体移植排斥和耐受中的作用
基本信息
- 批准号:8099446
- 负责人:
- 金额:$ 40.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdverse effectsAffectAlloantigenAllogenicAllograft ToleranceAllograftingAnimalsAntibody TherapyAntigen-Presenting CellsAntigensApoptosisAsthmaAutoimmunityBehaviorBlocking AntibodiesBreedingCD28 geneCD4 Positive T LymphocytesCD8B1 geneCardiacCell DeathCell Differentiation processCellsChimeric ProteinsChronicClinicalClonal ExpansionCollaborationsComplexDataDevelopmentEngraftmentExperimental Autoimmune EncephalomyelitisFamilyFibrosisFunctional disorderGene ExpressionGene TargetingGenerationsGoalsGraft RejectionHelper-Inducer T-LymphocyteHumanHypersensitivityIL2RA geneImmune responseImmunoglobulinsImmunosuppressionImmunosuppressive AgentsIn VitroKnock-in MouseLaboratoriesLeadLifeLigandsLinkMHC Class II GenesMaintenanceMalignant NeoplasmsMediatingMemoryMetabolic DiseasesModelingMucin 1 proteinMucinsMusOpportunistic InfectionsOrgan TransplantationOutcomePathway interactionsPatientsPeptidesPharmaceutical PreparationsPlayPrimatesProceduresProcessProductionProteinsRegulationRegulatory T-LymphocyteReporterResearch PersonnelRodentRoleSTAT4 geneSTAT6 geneSignal TransductionSirolimusSkinSkin TransplantationSolidSpecificitySurvival RateT cell differentiationT cell regulationT cell responseT-Cell ActivationT-Cell Activation PathwayT-LymphocyteTNFRSF5 geneTNFSF5 geneTechnologyTh1 CellsTh1/Th2 Differentiation PathwayTh2 CellsTransgenic AnimalsTransgenic MiceTransgenic ModelTranslatingTransplantationTransplantation ToleranceUniversitiesVascular DiseasesWithdrawalallograft rejectionanergybasecardiovascular disorder riskchemokineclinically relevantcytokinedesignend-stage organ failuregraft failureheart allograftimmunoregulationimprovedin vivoinnovationinsightisoimmunityknockout genenonhuman primatenovelnovel strategiesperipheral tolerancepreventprogramsreceptorresponseskin allografttool
项目摘要
DESCRIPTION (provided by applicant): The T cell immunoglobulin mucin (TIM) family of novel receptor-ligand pairs plays important roles in T cell activation, differentiation and effector function, and in regulation of immune responses in autoimmunity and allergy/asthma, but its functions in alloimmune responses are poorly defined. Our central hypothesis, supported by extensive preliminary data, is that the TIM-1 :TIM-4 pathway, by affecting T helper cell differentiation, play important roles in alloimmune responses and tolerance in vivo. In addition, data from our group and others suggest a possible role of the TIM family of molecules in the function of regulatory T cells. The main goal of this proposal is to define the role and understand the mechanisms of action of the TIM-1:TIM-4 pathway in regulating alloimmune responses in vivo as a means of achieving durable and reproducible tolerance in murine transplant models. Unique tools, including anti-TIM agonistic and blocking antibodies and fusion proteins, and gene knockout and TCR transgenic animals will be used to dissect the functions of the TIM-1 :TIM-4 pathway in alloimmunity using vascularized transplant models of acute and chronic rejection, and stringent models of skin transplantation. More specifically, the aims of the project are: 1. To investigate the functions of the TIM-1 :TIM-4 pathway in alloimmune responses in vivo. 2. To investigate the functions of the TIM-1 :TIM-4 pathway in chronic rejection. 3. To investigate the mechanisms of action of targeting the TIM-1 :TIM-4 pathway in alloreactivity and tolerance via defining the fate of alloreactive T cells in vivo. 4. To study the role of the TIM-1 :TIM-4 pathway in generation/function of Foxp3 regulatory T cells in vivo. Overall, our specific aims describe complimentary approaches that should lead to the development of innovative strategies to permit solid organ graft acceptance without chronic rejection to translate to primates and humans.
描述(由申请人提供):新型受体-配体对的T细胞免疫球蛋白粘蛋白(TIM)家族在T细胞活化、分化和效应子功能中以及在自身免疫和过敏/哮喘的免疫应答调节中发挥重要作用,但其在同种免疫应答中的功能定义不清。我们的中心假设,支持广泛的初步数据,是TIM-1:TIM-4途径,通过影响T辅助细胞的分化,在同种免疫反应和耐受体内发挥重要作用。此外,来自我们小组和其他人的数据表明TIM家族分子在调节性T细胞功能中的可能作用。该提案的主要目标是定义TIM-1:TIM-4途径在体内调节同种免疫应答中的作用并理解其作用机制,作为在小鼠移植模型中实现持久和可再现耐受性的手段。独特的工具,包括抗TIM激动性和阻断性抗体和融合蛋白,以及基因敲除和TCR转基因动物将用于使用急性和慢性排斥的血管化移植模型和皮肤移植的严格模型来剖析同种免疫中TIM-1:TIM-4通路的功能。更具体地说,该项目的目标是:1。目的探讨TIM-1:TIM-4通路在同种异体免疫应答中的作用。2.目的探讨TIM-1:TIM-4通路在慢性排斥反应中的作用。3.通过确定同种异体反应性T细胞在体内的命运,研究靶向TIM-1:TIM-4通路在同种异体反应性和耐受中的作用机制。4.研究TIM-1:TIM-4通路在体内Foxp 3调节性T细胞的产生/功能中的作用。总的来说,我们的具体目标描述了互补的方法,这些方法应该导致创新策略的发展,以允许实体器官移植物的接受,而不会产生慢性排斥反应,从而转化为灵长类动物和人类。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rejection and regulation: a tight balance.
- DOI:10.1097/mot.0b013e32834ef52a
- 发表时间:2012-02
- 期刊:
- 影响因子:2.2
- 作者:Ashoor IF;Najafian N
- 通讯作者:Najafian N
The emerging role of the TIM molecules in transplantation.
蒂姆分子在移植中的新兴作用。
- DOI:10.1111/j.1600-6143.2011.03727.x
- 发表时间:2011-10
- 期刊:
- 影响因子:0
- 作者:Yeung MY;McGrath M;Najafian N
- 通讯作者:Najafian N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mohamed H Sayegh其他文献
This information is current as Survival of Allogeneic Heart Transplants Response to Cardiac Myosin Can Prolong Modulation of Tissue-Specific Immune
此信息是最新的,因为同种异体心脏移植的存活对心肌肌球蛋白的反应可以延长组织特异性免疫的调节
- DOI:
- 发表时间:
2002 - 期刊:
- 影响因子:0
- 作者:
E. Fedoseyeva;Koji Kishimoto;H. Rolls;B. Illigens;V. Dong;A. Valujskikh;Peter S. Heeger;Mohamed H Sayegh;Gilles Benichou - 通讯作者:
Gilles Benichou
Effect of gonadectomy on epidermal growth factor values in the gastrointestinal tract of male and female CD-1 mice.
性腺切除术对雄性和雌性 CD-1 小鼠胃肠道表皮生长因子值的影响。
- DOI:
10.1136/gut.36.4.558 - 发表时间:
1995 - 期刊:
- 影响因子:24.5
- 作者:
Mohamed H Sayegh;J. Elder - 通讯作者:
J. Elder
The arduous road to achieving an immunosuppression-free state in kidney transplant recipients
肾移植受者实现无免疫抑制状态的艰辛之路
- DOI:
10.1038/ncpneph0568 - 发表时间:
2007 - 期刊:
- 影响因子:0
- 作者:
M. Ansari;Mohamed H Sayegh - 通讯作者:
Mohamed H Sayegh
Regulating rejection with cell therapy
用细胞疗法调节排斥反应
- DOI:
10.1038/nbt0208-191 - 发表时间:
2008-02-01 - 期刊:
- 影响因子:41.700
- 作者:
Mohamed H Sayegh;Howard L Weiner - 通讯作者:
Howard L Weiner
Mohamed H Sayegh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mohamed H Sayegh', 18)}}的其他基金
Novel Therapies of Chronic Allograft Dysfunction
慢性同种异体移植功能障碍的新疗法
- 批准号:
7869850 - 财政年份:2009
- 资助金额:
$ 40.45万 - 项目类别:
Role of Novel T Cell Costimulatory Pathways in Allograft Rejection and Tolerance
新型 T 细胞共刺激途径在同种异体移植物排斥和耐受中的作用
- 批准号:
7644026 - 财政年份:2008
- 资助金额:
$ 40.45万 - 项目类别:
The Role of TIM-1: TIM-4 Pathway in Allograft Rejection and Tolerance
TIM-1:TIM-4 通路在同种异体移植排斥和耐受中的作用
- 批准号:
7451032 - 财政年份:2007
- 资助金额:
$ 40.45万 - 项目类别:
The Role of TIM-1: TIM-4 Pathway in Allograft Rejection and Tolerance
TIM-1:TIM-4 通路在同种异体移植排斥和耐受中的作用
- 批准号:
7643464 - 财政年份:2007
- 资助金额:
$ 40.45万 - 项目类别:
The Role of TIM-1: TIM-4 Pathway in Allograft Rejection and Tolerance
TIM-1:TIM-4 通路在同种异体移植排斥和耐受中的作用
- 批准号:
7321218 - 财政年份:2007
- 资助金额:
$ 40.45万 - 项目类别:
The Role of TIM-1: TIM-4 Pathway in Allograft Rejection and Tolerance
TIM-1:TIM-4 通路在同种异体移植排斥和耐受中的作用
- 批准号:
7876993 - 财政年份:2007
- 资助金额:
$ 40.45万 - 项目类别:
Role of Novel T Cell Costimulatory Pathways in Allograft Rejection and Tolerance
新型 T 细胞共刺激途径在同种异体移植物排斥和耐受中的作用
- 批准号:
7338983 - 财政年份:2007
- 资助金额:
$ 40.45万 - 项目类别:
DEVELOPMENT OF ANTIGEN-SPECIFIC ASSAYS INDICATIVE OF DONOR-SPECIFIC TOLERANCE
指示供体特异性耐受性的抗原特异性检测的开发
- 批准号:
7204532 - 财政年份:2005
- 资助金额:
$ 40.45万 - 项目类别:
Novel Therapies of Chronic Allograft Dysfunction
慢性同种异体移植功能障碍的新疗法
- 批准号:
7489372 - 财政年份:2004
- 资助金额:
$ 40.45万 - 项目类别:
Novel Therapies of Chronic Allograft Dysfunction
慢性同种异体移植功能障碍的新疗法
- 批准号:
7117837 - 财政年份:2004
- 资助金额:
$ 40.45万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 40.45万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 40.45万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 40.45万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 40.45万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 40.45万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 40.45万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 40.45万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 40.45万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 40.45万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 40.45万 - 项目类别:
Research Grant














{{item.name}}会员




